78 related articles for article (PubMed ID: 7668350)
1. Mitochondrial damage results in a reversible increase in lysosomal storage material in lymphoblasts from patients with juvenile neuronal ceroid-lipofuscinosis (Batten Disease).
Boriack RL; Cortinas E; Bennett MJ
Am J Med Genet; 1995 Jun; 57(2):301-3. PubMed ID: 7668350
[TBL] [Abstract][Full Text] [Related]
2. Disease-specific pathology in neurons cultured from sheep affected with ceroid lipofuscinosis.
Hughes SM; Kay GW; Jordan TW; Rickards GK; Palmer DN
Mol Genet Metab; 1999 Apr; 66(4):381-6. PubMed ID: 10191133
[TBL] [Abstract][Full Text] [Related]
3. Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis.
Kieseier BC; Goebel HH
Am J Med Genet; 1995 Jun; 57(2):222-4. PubMed ID: 7668333
[TBL] [Abstract][Full Text] [Related]
4. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
[TBL] [Abstract][Full Text] [Related]
5. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
[TBL] [Abstract][Full Text] [Related]
6. Defective lysosomal arginine transport in juvenile Batten disease.
Ramirez-Montealegre D; Pearce DA
Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
[TBL] [Abstract][Full Text] [Related]
7. Tissue culture loading test with storage granules from animal models of neuronal ceroid-lipofuscinosis (Batten disease): testing their lysosomal degradability by normal and Batten cells.
Elleder M; Drahota Z; Lisá V; Mares V; Mandys V; Müller J; Palmer DN
Am J Med Genet; 1995 Jun; 57(2):213-21. PubMed ID: 7668332
[TBL] [Abstract][Full Text] [Related]
8. Palmitate oxidation in muscle mitochondria of patients with the juvenile form of neuronal ceroid-lipofuscinosis.
Majander A; Pihko H; Santavuori P
Am J Med Genet; 1995 Jun; 57(2):298-300. PubMed ID: 7668349
[TBL] [Abstract][Full Text] [Related]
9. Translocation 10;18 in a patient with juvenile neuronal ceroid-lipofuscinosis (Batten disease).
Tuck-Muller CM; Dyken PR; Li S; Chen H; Labbé E; Wertelecki W
Am J Med Genet; 1995 Jun; 57(2):168-71. PubMed ID: 7668324
[TBL] [Abstract][Full Text] [Related]
10. Batten disease fibroblasts in culture accumulate mitochondrial ATP synthase subunit 9.
Tanner A; Dice JF
Cell Biol Int; 1995 Jan; 19(1):71-5. PubMed ID: 7613514
[TBL] [Abstract][Full Text] [Related]
11. You say lipofuscin, we say ceroid: defining autofluorescent storage material.
Seehafer SS; Pearce DA
Neurobiol Aging; 2006 Apr; 27(4):576-88. PubMed ID: 16455164
[TBL] [Abstract][Full Text] [Related]
12. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
[TBL] [Abstract][Full Text] [Related]
13. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
14. [Antioxidative therapy in ceroid lipofuscinosis].
Rotteveel JJ; Mullaart RA
Tijdschr Kindergeneeskd; 1989 Oct; 57(5):181-6. PubMed ID: 2815055
[TBL] [Abstract][Full Text] [Related]
15. Topographic variabilities of immunoreactivity to subunit c of mitochondrial ATP synthase and lectin binding in late infantile neuronal ceroid-lipofuscinosis.
Kida E; Wisniewski KE; Connell F
Am J Med Genet; 1995 Jun; 57(2):182-6. PubMed ID: 7668327
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation in Batten disease (neuronal ceroid-lipofuscinosis). Will it work? Preliminary studies on coculture experiments and on bone marrow transplant in late infantile Batten disease.
Lake BD; Henderson DC; Oakhill A; Vellodi A
Am J Med Genet; 1995 Jun; 57(2):369-73. PubMed ID: 7668365
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
18. Methylamine accumulation in cultured cells as a measure of the aqueous storage compartment in the laboratory diagnosis of genetic lysosomal diseases.
Kopitz J; Harzer K; Kohlschütter A; Zöller B; Blenck N; Cantz M
Am J Med Genet; 1996 May; 63(1):198-202. PubMed ID: 8723110
[TBL] [Abstract][Full Text] [Related]
19. Late-infantile Batten disease: purification of the subunit c of the mitochondrial ATP synthase from storage material.
Hagopian K; Lake BD; Winchester BG; Clark JB
Am J Med Genet; 1995 Jun; 57(2):272-8. PubMed ID: 7668344
[TBL] [Abstract][Full Text] [Related]
20. In-utero and post-delivery supplementation of motor neuron degeneration mutant mice with polyunsaturated fatty acids does not alter the clinical or pathological course.
Bennett MJ; Boriack RL; Birch DG
Neuropediatrics; 1997 Feb; 28(1):82-4. PubMed ID: 9151333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
